Sian Bigora
Equibles does not estimate personal net worth.
Get an email with a short summary when Processa Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get PCSA alertsAbout Sian Bigora
The proxy statement of Processa Pharmaceuticals, Inc. reports total compensation of $495,097 for Sian Bigora in fiscal 2025, including a base salary of $367,757. Disclosed compensation is on record for 6 fiscal years. Processa Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Processa Pharmaceuticals, Inc. includes George Ng (CEO and Board Member), Russell L. Skibsted (CFO), Russell Skibsted (CFO) and 7 others.
Affiliation history
-
Processa Pharmaceuticals, Inc. (PCSA)
Proxy statement
Current
Company network
Leadership on record at Processa Pharmaceuticals, Inc.
- George Ng CEO, Board Member
- Russell L. Skibsted CFO
- Russell Skibsted CFO
- David Young Board Member
- Geraldine Pannu Board Member
- James Neal Board Member
- James R. Neal Board Member
- Justin Yorke Board Member
- Khoso Baluch Board Member
- Sheila Gujrathi Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Processa Pharmaceuticals, Inc. (PCSA) | Former Chief Development and Regulatory Officer | $367,757 | $495,097 |
| 2024 | Processa Pharmaceuticals, Inc. (PCSA) | Former Chief Development and Regulatory Officer | $290,940 | $328,251 |
| 2023 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Development and Regulatory Officer | $160,200 | $321,702 |
| 2022 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Development Officer | $93,875 | $1,075,592 |
| 2021 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Development Officer | $87,500 | $460,078 |
| 2020 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Development Officer | $75,833 | $480,514 |
Recent activity
No call appearances or filed executive changes recorded yet.